Theialife
Manufacturing · United Arab Emirates · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Burjuman Office Tower Office L23/05-12 F...Phone Number
+91 8028410158Website
www.theialife.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Theialife
Theialife is a U.S. incorporated, late-stage clinical ophthalmology company dedicated to developing innovative therapies for ocular diseases, particularly focusing on pediatric myopia. Their lead asset, ND10, is the world's first oral therapy for early-onset pediatric myopia, set to enter global Phase III clinical trials in 2026. The company aims to transform standards of care and improve patients' lives through cutting-edge treatments that prevent sight deterioration and restore vision. With a commitment to addressing unmet needs in global ophthalmology, Theialife leverages a proprietary platform to advance unique therapies and formulations.Explore more
Theialife Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Theialife your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Theialife
Check if Theialife has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Theialife launches new products
Click to see if Theialife had a recent Job posting/layoffs
Check out if Theialife is spiking on competitors!
Earning: See what the market has to say on Theialife recently announced quarterly report
Theialife, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Theialife has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Theialife
Find 3 more new buyers
Company Profile Activity
Activity Insights
Theialife is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Theialife is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Theialife.
Theialife Tech Stack
A closer look at the technologies used by Theialife
See more technologies
Theialife News & Media
Theialife Appoints Thomas Ruggia as President and Chief Executive Officer to Advance Phase-3 Ready Oral Myopia Therapy and Scale Ophthalmology Platform
DOVER, Del., April 23, 2026 (GLOBE NEWSWIRE) -- Theialife, a late-stage clinical company advancing innovative therapeutic solutions for ocular diseases, today announced the appointment of Thomas Ruggia as President and Chief Executive Officer. Mr. Ruggia, based in New Jersey, will lead development, operational and corporate strategy as the Company prepares for anticipated milestones including the planned initiation of Phase 3 development for Thealife’s lead candidate, ND10. The company’s co-foun
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Theialife
Sign Up For FreeTo access detailed company insights
Theialife is a U.S. incorporated, late-stage clinical ophthalmology company dedicated to developing innovative therapies for ocular diseases, particularly focusing on pediatric myopia. Their lead asset, ND10, is the world's first oral therapy for early-onset pediatric myopia, set to enter global Phase III clinical trials in 2026. The company aims t... Read More
